Skip to content
Research Article Open access CC BY 4.0

Evaluation of Stability and TLC Fingerprinting of the Artemether Component in Artemether-Lumefantrine Combination Suspension Formulations Available in Nigeria Pharmaceutical Market

Benjamin U. Ebeshi, Samuel J. Bunu, Chika L. Egemba, Edebi N. Vaikosen, Adesegun Kashimawo

Asian Journal of Research in Medical and Pharmaceutical Sciences · pp. 183–190 · Published 23 Dec 2023

10.9734/ajrimps/2023/v12i4241

Abstract

Aim: Artemether is the main component of the artemisinin-based combination therapy (ACT), used in the management of malaria infection caused by Plasmodium falciparum. Hence, its stability and conformation to pharmacopeia standards are necessary for use. The study aimed to review the first-order derivative spectrophotometric method for simultaneous estimation of artemether and its derivatives in pure and combined formulations, and their stability profiles, then develop a simple, precise, and fast technique for their rapid physicochemical analysis. Methodology: Thin-layer chromatographic (TLC) Fingerprinting principles were used in the analysis. Artemether and its derivatives were spotted on the TLC chromatograms after adding 25 mL of the suspension to a mixture of 100 mL of distilled water and 4 mL of NaOH, extracting the mixture with 60 mL of dichloromethane (DCM), drying, and sonicating the residue with 20 mL of the solvent. It was centrifuged, and the clear supernatant was spotted on the TLC plates. Results: The color test results revealed the presence of the artemether compound in the reference standard as well as the six brands of suspensions (A, B, C, D, E, and F) utilized in the study. Artemether melting point was obtained between 86 - 89 °C; within the International Pharmacopeia specified range. The chromatograms of Artemether and derivatives showed Rf values of 0.25 (impurity A), 0.3 (artenimol impurity B), 0.35 (impurity C), 0.4 (α-artemether: impurity D), and 0.55 (artemether). Conclusion: The devised method can be applied to the routine quality control analysis of artemether-lumefantrine suspension in addition to existing analytical techniques.

Artemether assay fingerprint lumefantrine malaria quality control stability

References (18)

  1. 1 The National Center for Biotechnology Information [DOI]
  2. 2 Artemisinin-Based Combination Treatment of Falciparum Malaria [DOI]
  3. 3 Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine [DOI]
  4. 4 Separation Tecniques: CHROMATOGRAPHY [DOI]
  5. 5 Formulations for children: problems and solutions [DOI]
  6. 6 Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine [DOI]
  7. 7 Anticancer effect of antimalarial artemisinin compounds [DOI]
  8. 8 Artemisinin Combination Therapy for Malaria: Beyond Good Efficacy [DOI]
  9. 9 Drug stability: principles and practices [DOI]
  10. 10 Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies [DOI]
  11. 11 A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya [DOI]
  12. 12 Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia [DOI]
  13. 13 Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria [DOI]
  14. 14 Structural Insights into the Theoretical Model of Plasmodium falciparum NADH Dehydrogenase and its Interaction with Artemisinin and Derivatives: Towards Global Health Therapeutics [DOI]
  15. 15 Drug Interactions with Oral Contraceptives [DOI]
  16. 16 The role of assay methods in characterizing the quality of bulk pharmaceuticals [DOI]
  17. 17 Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria [DOI]
  18. 18 Clinical significance of sequestration in adults with severe malaria [DOI]

Cited by 2

Simultaneous UV-spectrophotometric determination of tertiary components in FDC of lamivudine, tenofovir disoproxil fumarate, and efavirenz in solid dose formulation

Edebi N Vaikosen, Faithful H Kpun, Samuel J Bunu · International Journal of Advanced Biochemistry Research · 2024

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

37

Page views

0

PDF downloads

3

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.